{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:23:13Z","timestamp":1791397393083,"version":"4.3.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:00:00Z","timestamp":1308873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:00:00Z","timestamp":1308873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/leu.2011.156","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T08:50:17Z","timestamp":1308905417000},"page":"1869-1876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"25","author":[{"given":"D","family":"Lenze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Leoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Volinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C G","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"De Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Githanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Nyagol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Palatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Rogena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,24]]},"reference":[{"key":"BFleu2011156_CR1","unstructured":"WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC: Lyon, 2008."},{"key":"BFleu2011156_CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0308-2261(82)80005-2","volume":"11","author":"H Stein","year":"1982","unstructured":"Stein H, Gerdes J, Mason DY . The normal and malignant germinal centre. Clin Haematol 1982; 11: 531\u2013559.","journal-title":"Clin Haematol"},{"key":"BFleu2011156_CR3","first-page":"1398","volume":"147","author":"J Tamaru","year":"1995","unstructured":"Tamaru J, Hummel M, Marafioti T, Kalvelage B, Leoncini L, Minacci C et al. Burkitt\u2032s lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am J Pathol 1995; 147: 1398\u20131407.","journal-title":"Am J Pathol"},{"key":"BFleu2011156_CR4","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood.V85.8.2176.bloodjournal8582176","volume":"85","author":"CJ Chapman","year":"1995","unstructured":"Chapman CJ, Mockridge CI, Rowe M, Rickinson AB, Stevenson FK . Analysis of VH genes used by neoplastic B cells in endemic Burkitt\u2032s lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood 1995; 85: 2176\u20132181.","journal-title":"Blood"},{"key":"BFleu2011156_CR5","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood.V77.7.1516.1516","volume":"77","author":"B Shiramizu","year":"1991","unstructured":"Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A et al. Patterns of chromosomal breakpoint locations in Burkitt\u2032s lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516\u20131526.","journal-title":"Blood"},{"key":"BFleu2011156_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1470-2045(04)01650-X","volume":"5","author":"CA van den Bosch","year":"2004","unstructured":"van den Bosch CA . Is endemic Burkitt\u2032s lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol 2004; 5: 738\u2013746.","journal-title":"Lancet Oncol"},{"key":"BFleu2011156_CR7","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1073\/pnas.83.9.2984","volume":"83","author":"PG Pelicci","year":"1986","unstructured":"Pelicci PG, Knowles DM, Magrath I, Dalla-Favera R . Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1986; 83: 2984\u20132988.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011156_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","volume":"106","author":"C Bellan","year":"2005","unstructured":"Bellan C, Lazzi S, Hummel M, Palummo N, de Santi M, Amato T et al. Immunoglobulin gene analysis reveals two distinct cells of origin for EBV positive and EBV negative Burkitt\u2032s lymphomas. Blood 2005; 106: 1031\u20131036.","journal-title":"Blood"},{"key":"BFleu2011156_CR9","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF et al. A biologic definition of Burkitt\u2032s lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419\u20132430.","journal-title":"N Engl J Med"},{"key":"BFleu2011156_CR10","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ et al. Molecular diagnosis of Burkitt\u2032s lymphoma. N Engl J Med 2006; 354: 2431\u20132442.","journal-title":"N Engl J Med"},{"key":"BFleu2011156_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V . The C elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843\u2013854.","journal-title":"Cell"},{"key":"BFleu2011156_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ng865","volume":"30","author":"EC Lai","year":"2002","unstructured":"Lai EC . Micro RNAs are complementary to 3\u2032 UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002; 30: 363\u2013364.","journal-title":"Nat Genet"},{"key":"BFleu2011156_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281\u2013297.","journal-title":"Cell"},{"key":"BFleu2011156_CR14","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1126\/science.1088060","volume":"303","author":"X Chen","year":"2004","unstructured":"Chen X . A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development. Science 2004; 303: 2022\u20132025.","journal-title":"Science"},{"key":"BFleu2011156_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0092-8674(03)00231-9","volume":"113","author":"J Brennecke","year":"2003","unstructured":"Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM . Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003; 113: 25\u201336.","journal-title":"Cell"},{"key":"BFleu2011156_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0960-9822(03)00250-1","volume":"13","author":"P Xu","year":"2003","unstructured":"Xu P, Vernooy SY, Guo M, Hay BA . The Drosophila microRNA mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 2003; 13: 790\u2013795.","journal-title":"Curr Biol"},{"key":"BFleu2011156_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2007.03.008","volume":"129","author":"QJ Li","year":"2007","unstructured":"Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147\u2013161.","journal-title":"Cell"},{"key":"BFleu2011156_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"CZ Chen","year":"2004","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP . MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83\u201386.","journal-title":"Science"},{"key":"BFleu2011156_CR19","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1101\/gad.1565607","volume":"21","author":"D O\u2019Carroll","year":"2007","unstructured":"O\u2019Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, Enright AJ et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev 2007; 21: 1999\u20132004.","journal-title":"Genes Dev"},{"key":"BFleu2011156_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2008.02.020","volume":"132","author":"SB Koralov","year":"2008","unstructured":"Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132: 860\u2013874.","journal-title":"Cell"},{"key":"BFleu2011156_CR21","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065\u20137070.","journal-title":"Cancer Res"},{"key":"BFleu2011156_CR22","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257\u20132261.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011156_CR23","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"PS Eis","year":"2005","unstructured":"Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102: 3627\u20133632.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011156_CR24","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/ijc.22800","volume":"121","author":"CH Lawrie","year":"2007","unstructured":"Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 2007; 121: 1156\u20131161.","journal-title":"Int J Cancer"},{"key":"BFleu2011156_CR25","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","volume":"113","author":"R Malumbres","year":"2009","unstructured":"Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113: 3754\u20133764.","journal-title":"Blood"},{"key":"BFleu2011156_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","volume":"142","author":"A Roehle","year":"2008","unstructured":"Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 2008; 142: 732\u2013744.","journal-title":"Br J Haematol"},{"key":"BFleu2011156_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","volume":"9","author":"M Pfreundschuh","year":"2008","unstructured":"Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008; 9: 105\u2013116.","journal-title":"Lancet Oncol"},{"key":"BFleu2011156_CR28","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0046-8177(98)90258-1","volume":"29","author":"S Lazzi","year":"1998","unstructured":"Lazzi S, Ferrari F, Nyongo A, Palummo N, de Milito A, Zazzi M et al. HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 1998; 29: 1285\u20131289.","journal-title":"Hum Pathol"},{"key":"BFleu2011156_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ejca.2004.10.025","volume":"41","author":"A Noske","year":"2005","unstructured":"Noske A, Denkert C, Schober H, Sers C, Zhumabayeva B, Weichert W et al. Loss of Gelsolin expression in human ovarian carcinomas. Eur J Cancer 2005; 41: 461\u2013469.","journal-title":"Eur J Cancer"},{"key":"BFleu2011156_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","volume":"8","author":"RA Ventura","year":"2006","unstructured":"Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 2006; 8: 141\u2013151.","journal-title":"J Mol Diagn"},{"key":"BFleu2011156_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2141.1992.tb06945.x","volume":"82","author":"M Hummel","year":"1992","unstructured":"Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H . EBV infection patterns in Hodgkin\u2032s disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 1992; 82: 689\u2013694.","journal-title":"Br J Haematol"},{"key":"BFleu2011156_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nprot.2008.14","volume":"3","author":"CG Liu","year":"2008","unstructured":"Liu CG, Calin GA, Volinia S, Croce CM . MicroRNA expression profiling using microarrays. Nat Protoc 2008; 3: 563\u2013578.","journal-title":"Nat Protoc"},{"key":"BFleu2011156_CR33","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.","journal-title":"Genome Biol"},{"key":"BFleu2011156_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275\u2013282.","journal-title":"Blood"},{"key":"BFleu2011156_CR35","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1111\/j.1742-4658.2009.07237.x","volume":"276","author":"LM Guo","year":"2009","unstructured":"Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M et al. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 2009; 276: 5537\u20135546.","journal-title":"FEBS J"},{"key":"BFleu2011156_CR36","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D . NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481\u201312486.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011156_CR37","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1038\/sj.onc.1210147","volume":"26","author":"J Kluiver","year":"2007","unstructured":"Kluiver J, van den BA, de Jong D, Blokzijl T, Harms G, Bouwman E et al. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 2007; 26: 3769\u20133776.","journal-title":"Oncogene"},{"key":"BFleu2011156_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43\u201350.","journal-title":"Nat Genet"},{"key":"BFleu2011156_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T et al. c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762\u2013765.","journal-title":"Nature"},{"key":"BFleu2011156_CR40","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","volume":"112","author":"S Sander","year":"2008","unstructured":"Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TFE et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 2008; 112: 4202\u20134212.","journal-title":"Blood"},{"key":"BFleu2011156_CR41","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O\u2032Donnell","year":"2005","unstructured":"O\u2032Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839\u2013843.","journal-title":"Nature"},{"key":"BFleu2011156_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ncb2024","volume":"12","author":"L Ma","year":"2010","unstructured":"Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D et al. miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12: 247\u2013256.","journal-title":"Nat Cell Biol"},{"key":"BFleu2011156_CR43","doi-asserted-by":"publisher","first-page":"e2420","DOI":"10.1371\/journal.pone.0002420","volume":"3","author":"CH Wang","year":"2008","unstructured":"Wang CH, Lee DY, Deng Z, Jeyapalan Z, Lee SC, Kahai S et al. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One 2008; 3: e2420.","journal-title":"PLoS One"},{"key":"BFleu2011156_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1261\/rna.2146903","volume":"9","author":"M Lagos-Quintana","year":"2003","unstructured":"Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T . New microRNAs from mouse and human. RNA 2003; 9: 175\u2013179.","journal-title":"RNA"},{"key":"BFleu2011156_CR45","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature06174","volume":"449","author":"L Ma","year":"2007","unstructured":"Ma L, Teruya-Feldstein J, Weinberg RA . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682\u2013688.","journal-title":"Nature"},{"key":"BFleu2011156_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503\u2013511.","journal-title":"Nature"},{"key":"BFleu2011156_CR47","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937\u20131947.","journal-title":"N Engl J Med"},{"key":"BFleu2011156_CR48","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa050995","volume":"353","author":"GA Calin","year":"2005","unstructured":"Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793\u20131801.","journal-title":"N Engl J Med"},{"key":"BFleu2011156_CR49","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834\u2013838.","journal-title":"Nature"},{"key":"BFleu2011156_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/gcc.20273","volume":"45","author":"J Kluiver","year":"2006","unstructured":"Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ et al. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 2006; 45: 147\u2013153.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2011156_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/path.1825","volume":"207","author":"J Kluiver","year":"2005","unstructured":"Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243\u2013249.","journal-title":"J Pathol"},{"key":"BFleu2011156_CR52","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","volume":"149","author":"K Klapproth","year":"2010","unstructured":"Klapproth K, Wirth T . Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol 2010; 149: 484\u2013497.","journal-title":"Br J Haematol"},{"key":"BFleu2011156_CR53","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/j.1349-7006.2007.00531.x","volume":"98","author":"H Tagawa","year":"2007","unstructured":"Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M . Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 2007; 98: 1482\u20131490.","journal-title":"Cancer Sci"},{"key":"BFleu2011156_CR54","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1365-2141.2010.08111.x","volume":"149","author":"JL Robertus","year":"2010","unstructured":"Robertus JL, Kluiver J, Weggemans C, Harms G, Reijmers RM, Swart Y et al. MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol 2010; 149: 896\u2013899.","journal-title":"Br J Haematol"},{"key":"BFleu2011156_CR55","doi-asserted-by":"publisher","first-page":"13520","DOI":"10.1073\/pnas.0804295105","volume":"105","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008; 105: 13520\u201313525.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011156_CR56","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1182\/blood-2010-08-301556","volume":"117","author":"PP Piccaluga","year":"2011","unstructured":"Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C et al. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood 2011; 117: 3596\u20133608.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:17:17Z","timestamp":1648736237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,24]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFleu2011156"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.156","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,24]]},"assertion":[{"value":"15 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}